ZTS FY 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$6.7B+6.6% YoY

Gross Profit

$4.5B66.8% margin

Operating Income

$2.3B34.0% margin

Net Income

$1.6B24.5% margin

EPS (Diluted)

$3.42

Cash Flow

Operating Cash Flow

$2.1B

Free Cash Flow

$1.7B

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$13.6B

Total Liabilities

$9.8B

Stockholders' Equity

$3.8B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.7B	$6.3B	+6.6%
Gross Profit	$4.5B	$4.1B	+8.4%
Operating Income	$2.3B	$2.0B	+12.4%
Net Income	$1.6B	$1.5B	+9.2%